Rachel Leong

Rachel Leong

Auto-generated profile, based on publicly available information

Rachel Leong

Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2024 in American Journal of Ophthalmology
Verified
Journal Article
Open access
RLRachel Leong
Rachel Leong
AVAmir Vosoughi
Amir Vosoughi
GSGuhan Sivakumar
Guhan Sivakumar
JMJonathan A. Micieli
Jonathan A. Micieli
To investigate the prevalence of non-person-first language (PFL) in consecutive general ophthalmology referrals to a single tertiary ophthalmology clinic. Retrospective cross-sectional study. Participants included Ophthalmology patients seen for their initial visit to a single tertiary ophthalmology clinic from July 2018 to December 2022. Ten randomly selected referrals from each day were screened for non-PFL as per the American Medical Association and American Psychological Association guidelines. Non-PFL was further categorized into general, diabetes, stigma, obesity, or ageism subcategories. The Chi-square test was used to evaluate associations between non-PFL use and referring provider gender and specialty, length of referral, and patient age and gender. A total of 2625 referrals were included in the study and 136 (5.2%) used non-PFL, such as referring to a person with diabetes as a "diabetic". Error types included Diabetes (38.2%), Stigma (30.9%), General (23.5%), Disability (8.8%), and Obesity (4.4%). Year of referral was predictive of non-PFL (P = .0016), with most occurring in 2020 (9.5%). Non-PFL was significantly more likely to occur in long length referrals compared to medium and short length referrals (16.2% vs. 5.1% vs. 3.5%, P < .001). Referring provider specialty was also predictive of non-PFL (P < .001) with most received by Family Medicine (8.3%), Optometry (4.4%), Emergency Medicine (0.62%), Ophthalmology (4.2%), Others (2.9%). Patient gender (P = .5563), patient age (P = .3466), and referring provider gender (P = .9057) were not predictive of non-PFL. Non-PFL use was most prevalent in 2020, with the most common referral sources being Family Medicine and Optometry. The highest proportions of non-PFL errors made were diabetes and stigma errors. Increased use of PFL in physician-physician communication can decrease intersectional stigma and promote inclusive patient care for ophthalmology patients.

5 June 2024 in European Journal of Ophthalmology
Verified
Journal Article
Open access
BTBrendan Tao
Brendan Tao
JXJim S. Xie
Jim S. Xie
RLRachel Leong
Rachel Leong
MXMatton Xia
Matton Xia
ANAnne Xuan-Lan Nguyen
Anne Xuan-Lan Nguyen
FKFaisal Khosa
Faisal Khosa
Purpose: This cross-sectional study evaluated the prevalence of inclusive author submission guidelines across ophthalmology journals. Methods: Journals were identified from the 2021 Journal Citations Report (Clarivate Analytics). Independent reviewers rated each author submission guideline as “inclusive” for satisfying at-least one of six criteria: i) included examples of gender inclusive language; ii) recommended the use of gender-inclusive language; iii) distinguished between sex and gender; iv) provided educational resources on gender-inclusive language; v) provided a policy permitting name changes (e.g., in case of gender and name transition); and/or vi) provided a statement of commitment to inclusivity. The primary objective was to investigate the proportion of journals with “gender-inclusive” author submission guidelines and the elements of the gender-inclusive content within these guidelines. A secondary objective was to review the association between “gender-inclusivity” in author submission guidelines with publisher, origin country, and journal/source/influence metrics (Clarivate Analytics). Results: Across 94 journals, 29.8% journals were rated as inclusive. Inclusive journals had significantly higher relative impact factor, citations, and article influence scores compared to non-inclusive journals. Of the 29.8% of inclusive journals, the three most common domains were inclusion of an inclusivity statement (71.4% of inclusive journals), distinguishing between sex and gender (67.9%), and provision of additional educational resources on gender reporting for authors (60.7%). Conclusion: A minority of ophthalmology journals have gender-inclusive author submission guidelines. Ophthalmology journals should update their submission guidelines to advance gender equity of both authors and study participants and promote the inclusion of gender-diverse communities.

14 April 2025 in Canadian Journal of Ophthalmology
Verified
Journal Article
Open access
RLRachel Leong
Rachel Leong
AVAmir R. Vosoughi
Amir R. Vosoughi
GSGuhan Sivakumar
Guhan Sivakumar
JMJonathan A. Micieli
Jonathan A. Micieli
To investigate the prevalence of non-person-first language (PFL) in neuro-ophthalmology referrals to a single tertiary ophthalmology clinic. Retrospective cross-sectional study. Participants included neuro-ophthalmology patients seen for their initial visit from July 2018 to December 2022. Ten randomly selected referrals from each day were screened. Non-PFL was further categorized as per American Medical Association and American Psychological Association guidelines. Associations between non-PFL and patient age and gender, referring provider gender and specialty, and year and length of referral, were evaluated using the χ2 test. A total of 2105 referrals were included in the study and 81 (3.8%) used non-PFL, such as referring to a person with glaucoma as a "glaucoma patient". Error types included general (38.3%), stigma (25.9%), diabetes (19.8%), disability (13.6%), and obesity (2.5%). Non-PFL was significantly more likely in long referrals compared with medium and short referrals (9.9% vs 3.1% vs 1.3%; p < 0.001). Referral year was predictive of non-PFL (p = 0.0006), with a significant increase from 2018 (1.7%) to 2021 (6.1%) and decrease in 2022 (2.6%). Patient age was also predictive of non-PFL (p = 0.0359), with the highest prevalence among patients 40-69 years old (5.4%). Patient gender (p = 0.3350), referring provider gender (p = 0.3571), and referring provider specialty (p = 0.1280) were not predictive of non-PFL. The highest proportions of non-PFL errors made were general and stigma errors. Non-PFL use was most prevalent in 2021, most commonly in referrals for patients aged 40-69 years. There exists a need for ongoing education and awareness around PFL use in physician-physician communication to enhance inclusive, nonstigmatizing care for neuro-ophthalmology patients.

19 October 2026 in Current Opinion in Supportive & Palliative Care
Verified
Journal Article
Closed access
RLRachel Leong
Rachel Leong
EMEmily MacMillan
Emily MacMillan
CYChristina Yang
Christina Yang
JSJapyjot Singh
Japyjot Singh
JCJefferson Chan
Jefferson Chan
JLJennifer Leigh
Jennifer Leigh
Purpose: Treatment-related nausea and vomiting (TRNV) is among the most distressing and commonly reported adverse effects of antineoplastic therapy and can significantly impair patients’ quality of life (QoL). This review summarizes the evidence on how TRNV affects QoL across cancer types, treatment regimens, antiemetic strategies, and phases of TRNV. Recent findings: TRNV negatively affects all domains of QoL in patients with cancer, particularly physical and functional well-being. Studies consistently reported worsened fatigue, insomnia, appetite loss, pain, impaired activities of daily living, meal enjoyment, and role functioning. Psycho-social and cognitive effects were also observed, although findings were more variable. Despite advances in antiemetic interventions and supportive strategies, patients continued to experience a substantial symptom burden and worsened QoL following treatment. Most studies explored chemotherapy-related TRNV and did not focus on a specific cancer type. A wide range of QoL instruments were used, but no single tool comprehensively assessed all QoL domains while remaining specific to cancer-related nausea and vomiting. Summary: TRNV is associated with a significant decline in QoL among patients with cancer. Further research on QoL after TRNV within specific cancer types and treatment modalities and the development of a more comprehensive QoL tool are needed to improve cross-study comparability and to better understand patient outcomes.